Marijn Dekkers

Marijn Dekkers
Name	Marijn Dekkers
Birth date	1957-11-06
Birth place	Eindhoven, Netherlands
Nationality	Dutch
Alma mater	Delft University of Technology, University of Twente
Occupation	Chemist, executive, manager
Known for	CEO of Thermo Fisher Scientific, CEO of Bayer AG

Marijn Dekkers (born 6 November 1957) is a Dutch-born chemist and business executive known for leading multinational chemical, pharmaceutical, and analytical companies. He served as chief executive officer of Thermo Fisher Scientific and of Bayer AG, and held senior positions at Alfred Nobel-related firms and specialty chemical corporations. Dekkers has been involved with global firms in the biotechnology and pharmaceutical sectors and has a background in industrial chemistry and materials science.

Early life and education

Dekkers was born in Eindhoven, North Brabant, and completed undergraduate and graduate studies in chemical engineering and materials science at Delft University of Technology and the University of Twente. During his formative years he was exposed to the Dutch industrial ecosystem that included firms such as Philips and the Dutch chemical cluster, while contemporary academic influences included researchers associated with Materials Science and polymer chemistry groups. His technical training linked him to networks that later interfaced with multinational corporations like Shell, AkzoNobel, and DSM.

Career

Dekkers began his career in technology and materials roles within the specialty chemicals and consumer products sectors, progressing through management posts that bridged research, product development, and commercial strategy. He held senior roles at companies comparable to General Electric and Solvay, and later moved into leadership positions at major life sciences and pharmaceutical firms such as Solutia-style businesses and multinational conglomerates. Over time his portfolio expanded to include corporate development, mergers and acquisitions, and operational restructuring common to firms like Pfizer, Merck & Co., and GlaxoSmithKline.

Leadership at Thermo Fisher Scientific

As chief executive officer and chairman of Thermo Fisher Scientific—a global supplier of analytical instruments, reagents, and laboratory services—Dekkers led strategic initiatives to integrate acquisitions and scale global operations across regions including North America, Europe, and Asia. Under his tenure, the company aligned with large institutional customers such as National Institutes of Health, academic consortia like European Molecular Biology Laboratory, and industrial partners including Novartis and Bristol-Myers Squibb. The corporate strategy emphasized growth in areas served by firms such as Agilent Technologies, PerkinElmer, and Danaher Corporation, and engaged with regulatory environments involving agencies like the Food and Drug Administration and the European Medicines Agency.

Tenure at Bayer and other corporate roles

Dekkers served as chief executive officer of Bayer AG, overseeing business units in pharmaceuticals, consumer health, and crop science during a period of portfolio review and strategic repositioning. His leadership intersected with corporate events resembling the corporate integration challenges seen in mergers like Monsanto and the competitive dynamics involving Syngenta and BASF. He also held board or advisory roles with multinational corporations and financial institutions comparable to Johnson & Johnson, BlackRock, and Berkshire Hathaway-level governance contexts, and participated in industry forums such as those organized by Business Roundtable and the World Economic Forum.

Scientific contributions and patents

Trained as a chemist and materials scientist, Dekkers contributed to product development pipelines and oversaw teams that generated intellectual property in areas akin to polymer formulations, analytical chemistry instrumentation, and bioprocessing technologies. His stewardship encompassed patent strategies and filings similar to portfolios held by Thermo Fisher Scientific, GE Healthcare, and 3M, addressing technologies used in laboratories, diagnostics, and production facilities. Dekkers' work involved collaborations with research institutions like Massachusetts Institute of Technology, Stanford University, and European technical universities, aligning corporate R&D with translational projects in life sciences.

Personal life and honors

Dekkers has been recognized with corporate and industry awards reflecting executive leadership and innovation, comparable to honors granted by organizations such as Financial Times, Fortune, and trade associations in the chemical industry and biotechnology sectors. He has participated in philanthropic and educational initiatives, engaging with institutions similar to Harvard University, Johns Hopkins University, and European research foundations. Dekkers resides between business centers in Europe and North America and maintains involvement in executive networks, corporate governance bodies, and advisory panels connected to global industry leaders.

Category:Dutch chief executives Category:1957 births Category:Living people